Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 11448094)

1.

The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.

McCartan D, Bell R, Green JF, Campbell C, Trimble K, Pickering A, King DJ.

J Psychopharmacol. 2001 Jun;15(2):96-104.

PMID:
11448094
2.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
3.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
4.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
5.

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Weiner I.

Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97. Epub 2003 Feb 25. Review.

PMID:
12601500
6.

Psychomotor impairment and cognitive disturbances induced by neuroleptics.

King DJ.

Acta Psychiatr Scand Suppl. 1994;380:53-8. Review.

PMID:
7914050
7.

[Effects of antidepressants on cognitive functions. Review of the literature].

Amado-Boccara I, Gougoulis N, Poirier-Littré MF, Galinowski A, Lôo H.

Encephale. 1994 Jan-Feb;20(1):65-77. Review. French.

PMID:
8174512
8.

The effect of neuroleptics on cognitive and psychomotor function.

King DJ.

Br J Psychiatry. 1990 Dec;157:799-811. Review.

PMID:
1981157
9.

The pharmacology of latent inhibition as an animal model of schizophrenia.

Moser PC, Hitchcock JM, Lister S, Moran PM.

Brain Res Brain Res Rev. 2000 Sep;33(2-3):275-307. Review.

PMID:
11011070
10.

Latent inhibition as a measure of learned inattention: some problems and solutions.

Lubow RE.

Behav Brain Res. 1997 Oct;88(1):75-83. Review.

PMID:
9401711
11.

Studies with alpidem in normal volunteers and anxious patients.

Morton S, Lader M.

Pharmacopsychiatry. 1990 May;23 Suppl 3:120-3. Review.

PMID:
1974071
12.

CANTAB battery: proposed utility in neurotoxicology.

Fray PJ, Robbins TW.

Neurotoxicol Teratol. 1996 Jul-Aug;18(4):499-504. Review.

PMID:
8866544
13.

Alpidem and psychological performance in elderly subjects.

Hindmarch I.

Pharmacopsychiatry. 1990 May;23 Suppl 3:124-8. Review.

PMID:
1974072
14.

A review of the psychomotor effects of paroxetine.

Hindmarch I.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:65-7. Review.

PMID:
1431014
15.

[Stroop test and schizophrenia].

Grapperon J, Delage M.

Encephale. 1999 Jan-Feb;25(1):50-8. Review. French.

PMID:
10205734
16.

Effects of antidepressants on cognitive functions: a review.

Amado-Boccara I, Gougoulis N, Poirier Littré MF, Galinowski A, Lôo H.

Neurosci Biobehav Rev. 1995 Fall;19(3):479-93. Review.

PMID:
7566749
17.

The positive symptoms of acute schizophrenia and latent inhibition in humans and animals: underpinned by the same process(es)?

Schmidt-Hansen M, Le Pelley M.

Cogn Neuropsychiatry. 2012 Nov;17(6):473-505. doi: 10.1080/13546805.2012.667202. Epub 2012 Mar 26. Review.

PMID:
22443090
18.

Neuropsychological side effects of beta-blockers.

Dimsdale JE, Newton RP, Joist T.

Arch Intern Med. 1989 Mar;149(3):514-25. Review.

PMID:
2563932
19.

Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

de Visser SJ, van der Post J, Pieters MS, Cohen AF, van Gerven JM.

Br J Clin Pharmacol. 2001 Feb;51(2):119-32. Review.

20.

The duration of the movement aftereffect as an index of psychiatric illness.

Harris J.

Perception. 1994;23(10):1145-53. Review.

PMID:
7899029
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk